Description
XENAZINE FOR THE SYRACUSE VAMC PHARMACY
First action · last action
2014-10-01 · 2014-10-01
Transactions
1
First transaction's obligation
$43,477
Base + all options value (sum of deltas)
$43,477
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P14A0003
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2014-10-01+$43,477= $43,477
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2014-10-01 | +$43,477 | $43,477 | XENAZINE FOR THE SYRACUSE VAMC PHARMACY |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI F1M3L99R99B3)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36F79726D0172 | NAC FEDERAL SUPPLY SCHEDULE (36F797) · 6505 · DRUGS AND BIOLOGICALS | $0 | FY2026 |
| 36C24920N0537 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $25,476 | FY2020 |
| 36C24920N0520 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $20,381 | FY2020 |
| 36C24920N0515 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0502 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
| 36C24920N0482 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6505 · DRUGS AND BIOLOGICALS | $10,191 | FY2020 |
Other recipients under 6505 from 242-NETWORK CONTRACT OFFICE 02 (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA52816F0890 | PFIZER INC | 242-NETWORK CONTRACT OFFICE 02 | $10,346 | FY2016 |
| VA52816F0808 | BAYER HEALTHCARE PHARMACEUTICALS INC | 242-NETWORK CONTRACT OFFICE 02 | $16,180 | FY2016 |
| VA52816F0388 | CSL BEHRING L.L.C. | 242-NETWORK CONTRACT OFFICE 02 | $1,097 | FY2016 |
| VA24016E0142 | MCKESSON CORPORATION | 242-NETWORK CONTRACT OFFICE 02 | $5,517,543 | FY2016 |
| VA52816J0701 | CEPHEID | 242-NETWORK CONTRACT OFFICE 02 | $234,636 | FY2016 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA52814F0367_3600_VA797P14A0003_3600 · retrieved 2026-09-26.